Motus GI Holdings Inc. (MOTS) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Motus GI Holdings Inc. (MOTS:NASDAQ), powered by AI.

Current Price
$0.00
Market Cap
81
Sector
Healthcare
What is the Motus GI Holdings Inc. stock price forecast?

Motus GI Holdings Inc. is currently trading at $0.00. View real-time AI analysis on Alpha Lenz.

What is Motus GI Holdings Inc. insider trading activity?

View the latest insider trading data for Motus GI Holdings Inc. on Alpha Lenz.

What is Motus GI Holdings Inc.'s P/E ratio?

View Motus GI Holdings Inc.'s valuation metrics on Alpha Lenz.

Motus GI Holdings Inc.

NASDAQ · MOTS
$0.00+0.00(+0.00%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Motus GI Holdings Inc.'s future dividend policy...
Alpha Chat Insight

Motus GI Holdings Inc.'s ROE is -454.3%. Explore profitability and growth together.

Ask for details

Company Overview

Motus GI Holdings Inc. is a medical technology company focused on enhancing clinical outcomes in gastrointestinal diagnostics. The company's primary innovation is the Pure-Vu System, a device designed to facilitate the cleaning of the gastrointestinal tract during colonoscopy and upper endoscopy procedures. The Pure-Vu System integrates seamlessly with standard gastroscopes and colonoscopes, allowing endoscopists to efficiently cleanse inadequately prepared colons intra-procedurally, thereby improving visualization and the overall quality of the exam. By supporting better cleansing, the system aims to minimize delays and incomplete procedures, which are significant challenges in inpatient colonoscopy. Motus GI Holdings Inc. addresses unmet needs in endoscopy by improving procedural efficiency, reducing hospital costs, and supporting better patient outcomes. Headquartered in Fort Lauderdale, Florida, and with subsidiaries in the U.S. and Israel, the company serves hospitals and healthcare providers seeking effective and cost-efficient solutions for gastrointestinal diagnostics.

CEOMr. Mark Pomeranz
SectorHealthcare
IndustryMedical Devices
Employees15

Company Statistics

FY 2023

Profile

$81.00Market Cap
$319.00KRevenue
0.00Shares Out
15Employees

Margins

-78.37%Gross
-3488.09%EBITDA
-3732.60%Operating
-4033.54%Pre-Tax
-4033.54%Net

Valuation

N/AP/E
N/AP/B
0.00EV/Sales
0.22EV/EBITDA
N/AP/FCF

Growth (CAGR)

48.20%Rev 3Yr
54.70%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-103.47%ROA
-454.34%ROE
-97.35%ROIC

Financial Health

$4.96MCash & Cash Equivalents
$-422.00KNet Debt
168.81%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Motus GI Holdings Inc. (ticker: MOTS) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 15 employees. Market cap is $81.

The current price is $0 with a P/E ratio of -x and P/B of -x.

ROE is -454.34% and operating margin is -3732.60%. Annual revenue is $319,000.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Motus GI Holdings Inc. (MOTS) Stock Forecast 2026 $0.00 — Price, Financials & Analyst Targets | Alpha Lenz